Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-06-11

EMA Authorised: Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate) — Zentiva k.s.

View source ↗

Summary

A European Medicines Agency authorisation for Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate) for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenofovir disoproxil Zentiva (tenofovir disoproxil phosphate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Zentiva k.s.. Decision date: 19/03/2025